「news2024年」の検索結果
72件：21～25件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
Identification of meibomian gland testosterone metabolites produced by tissue-intrinsic intracrine deactivation activity Khanh Tien Nguyen Pham 1, Takahito Miyake 1, Tomo Suzuki 2,3, Shigeru Kinoshita
http://www.senju.co.jp/english/rd/thesis/ -
Product Development Policy | Research & Development | SENJU Pharmaceutica
Corporate Strategy DivisionProduct Planning DepartmentDirectorYasunobu Maenaka With the management philosophy of “Good Company” and a company that shapes “Beyond eyesight,” we have developed products
http://www.senju.co.jp/english/rd/policy/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
Domestic Overseas Domestic 第72回日本実験動物学会総会 開催日：2025年5月21日～2025年5月23日 開催地：名古屋国際展示場（ポートメッセなごや） 千寿製薬におけるげっ歯類及びウサギの獣医学的ケア 山田 康太郎 第129回日本眼科学会総会 開催日：2025年4月17日～2025年4月20日 開催地：東京国際フォーラム ヒト角膜上皮細胞における新規TRPV1拮抗薬
http://www.senju.co.jp/english/rd/society/ -
Research and Development System | Research & Development | SENJU Pharmaceutica
All things in nature have a reason for being. Today’s common sense is not common sense tomorrow. This is our motto. Senju Pharmaceutical has unique research systems, such as international joint resear
http://www.senju.co.jp/english/rd/about/ -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap
http://www.senju.co.jp/english/rd/trial.html